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Objective: Endometriosis is a chronic inﬂammatory disease pathologically deﬁned as the presence of
endometrial-like tissue outside the uterine cavity. It is one of the most important diseases affecting
women of reproductive age. The process of endometriotic implant growth is mediated by many complex
interactions of immunologic, hormonal, genetic, and environmental mediators. Vitamin C (ascorbic acid),
besides playing a role in preventing invasion and metastasis, is an antioxidant having anti-inﬂammatory
and -angiogenic effects. In this study, we aimed to investigate the effect of vitamin C on the prevention
and regression of endometriotic implants in a rat model of endometriosis.
Materials and Methods: This was a prospective, comparative, experimental animal study. After endo-
metriotic implants were induced simultaneously, rats were divided into three groups. Group A was given
500mg/kg of intravenous vitamin C every 2 days, starting immediately after implantation (n¼ 11). All rats
had a second operation 21 days after the initial one and had the lesion volumes measured. Group B was
given 500mg/kg of intravenous vitamin C every 2 days, starting 21 days after this operation (n¼ 11). All rats
were sacriﬁced 21 days after the third operation. Implant volume, weight measurements, and histopath-
ological evaluation of the lesions were carried out. Group A received vitamin C throughout the study, while
Group C (n ¼ 11) was not given any medication. The ﬁndings in the three groups were compared.
Results: At the second laparotomy after the induction, Group A had the smallest implant volume with a
statistically signiﬁcant difference compared to Group B (p ¼ 0.012). The end-of-study volumes of
endometriotic implants of group B were signiﬁcantly smaller than the ﬁrst volumes (p < 0.05).
Conclusion: Intravenous vitamin C treatment might have a suppressive effect on the prevention of
endometriotic implant induction and regression of endometriotic implant volumes.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Endometriosis is described as the presence of endometrial
tissue (glandular epithelium and stroma) outside the uterine
cavity. It is a benign chronic inﬂammatory disease, associatedmen's Health Education and
ber: 34/4 Çankaya, Ankara,
ri).
bstetrics & Gynecology. Published bwith pain (chronic pelvic pain, dysmenorrhea, dyspareunia) and
infertility [1].
It is estimated to occur in 10% of all women [2] and is reported to
affect up to 60% of reproductive aged women with pelvic or infer-
tility symptoms [3,4]. This high prevalence in the infertile popula-
tion underlines its complex and multifactorial role in infertility,
having adverse effects on ovarian reserve, ovulation, tubal anatomy,
embryo quality, and implantation [5].
The pathophysiology of endometriosis is still not entirely clear,
and several theories have been proposed. During the pasty Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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ators, various genes, and oxidative stress have been emphasized
in the pathogenesis of endometriosis [6e12]. Recent studies imply
a potential role of oxidative stress in the activation of nuclear
factor-kappaB (NFkB), which stimulates inﬂammation and cell
proliferation and inhibits apoptosis of endometriotic cells, having
a major effect on the implantation and growth of endometriotic
foci [12e14].
Vitamin C (ascorbic acid) seems to have a far more important
role than being an antiscurvy vitamin alone. Besides playing a role
in preventing invasion and metastasis, it is an antioxidant having
anti-inﬂammatory and -angiogenic effects [15e18]. In vitro and
in vivo studies have demonstrated the anticancer activity of vitamin
C at pharmaceutical doses [19e21].
Vitamin C formulated as 2-3 endiol-L gulonic acid g lactone
having two enolic hydroxyl groups is a strong reducing agent.
Vitamin C is a part of the antioxidant protective system, as are
glutathione, a tocopherol, and nicotinamide [15e22]. Oxidants and
endotoxins stimulate cytokine secretion during the early stages of
the immune response via activation of NFkB. While vitamin C
directly limits cytokine secretion by radical scavenger function, it
also prevents cytokine secretion indirectly via intracellular sup-
pression of NFkB [11e14].
Although endometriosis occurs spontaneously only in humans
and some nonhuman primates, animal models are introduced for
further evaluation of pathophysiological mechanisms of this dis-
ease. Nonhuman primates may also be used for endometriosis
research; however, a high cost of animal handling is the major
concern that limits the use of baboons as an experimental model.
As rodents do not menstruate, an endometriosis model in a rodent
should necessarily be “induced.” Despite differences between
reproductive physiology of rodents and humans; these models of
endometriosis are thought to be able to achieve a convenient un-
derstanding of immune and endocrine interactions that are altered
during endometriosis [23].
There are two main types of experimental induction of endo-
metriosis in animal models such as rats: the homologous model
including autologous transplantation of uterine fragments into the
peritoneal cavity and the heterologous model involving hetero-
transplantation of human endometrial or endometriotic tissue to
immunodeﬁcient mice [23]. Another type of animal model is the
chicken chorioallantoic membrane assay model, which had been
used to assess the invasive and angiogenic properties of endome-
triosis and neoplastic lesions as well [23,24]. This model was not
attributable for investigating the immunological and inﬂammatory
mechanisms of endometriosis [23]. Vernon and Wilson [25], after
performing various interventions in their study in 1985, stated that
autotransplantation of uterine tissues directly to the peritoneal wall
was the only technique that achieved development of endometri-
otic implants made up of both glands and endometrial stroma.
There is only one study in the literature that has investigated the
effect of oral administration of vitamin C on the growth of endo-
metriotic cysts [26].
With the thought that it might be a cost-effective alternative
with a fewer-side-effect proﬁle to currently available hormonal
medical treatment strategies for endometriosis, the aim of the
present study was to investigate whether intravenously adminis-
trated vitamin C could have any prophylactic and therapeutic ef-
fects on the growth of endometriotic implants in a rat model of
endometriosis.
Materials and methods
This study was carried out in the Laboratory of the Animal
Research Center at the Ankara Education and Research Hospital,Ankara, Turkey. The Ankara Education and Research Hospital
Committee on the Use and Care of Animals approved the experi-
mental procedure on May 1, 2012, and all investigations were
performed in compliance with the European Commission Directive
86/609/EEC guidelines on the ethical use of animals.
Animals
Thirty-three sexually mature, cycling, female Wistar Albino Rats
(Laboratory of the Animal Research Center at the Ankara Education
and Research Hospital, Ankara, Turkey) weighing between 209 g
and 270 g were used in this study (Figure 1; ﬂowchart of the study).
The rats were checked for three consecutive regular estrous cycles
for homogeneity. Temperature, humidity ratio, and light/dark time
adjustment for roommaintenancewere 24± 1C, 55± 5%, and from
14-hour to 10-hour (light to dark) photoperiod, respectively. Water
and standard rat feed were provided ad libitum. The same team
under supervision of a veterinarian carried out maintenance of the
rats. All rats were allowed to acclimate in the vivarium for a 1-week
period before the experimental research.
Surgical procedures
All rats were anesthetized by intraperitoneal injection of 50 mg/
kg ketamine hydrochloride (Ketalar; Pﬁzer Pharmaceutical Co. Ltd,
Istanbul, Turkey) and 7 mg/kg xylazine hydrochloride (Rompun;
Bayer Turkish Chemical _Industry Trade Co. Ltd, _Istanbul, Turkey).
Anesthetized rats were immobilized in dorsal recumbence on a
standard surgical rat platform, and abdominal surfaces were
shaved and rinsed with 10% povidone iodine solution. All rats were
weighed under anesthesia prior to the ﬁrst operation, and this was
recorded separately.
First operation
According to the modiﬁcations of Vernon and Wilson [25] and
Uygur et al [27], surgical endometriosis was induced by trans-
planting autologous uterine tissue onto the peritoneal wall. A 3 cm
vertical midline incisionwas made and a 1 cm segment was excised
from the right uterine horn, the strip was cut longitudinally with
microscissors, and the endometrial mucosa was exposed. This
endometrial tissue was placed in a sterile saline solution. A tissue
fraction with an approximate size of 0.5 cm  0.3 cm was acquired
for implantation. This endometrial tissue was sutured on both ends
using a 4/0 polypropylene stitch to the inner surface of the peri-
toneum on the right side of the abdomen. The operation time was
limited to 15 minutes, in order to minimize the effect of environ-
ment on the drying of the tissues.
Rats were randomly divided into three groups (A, B, and C).
Simultaneously with the ﬁrst operation, intravenous vitamin C
(Redoxon ampoule, Bayer Turkish Chemical Industry Trade Co. Ltd.,
Istanbul, Turkey) 500 mg/kg was given every 2 days to the rats in
Group A (n ¼ 11) until the end of the study. The tail vein was used
for intravenous injection starting from the distal to the proximal
part. No drugs were given to the remaining 22 rats in Groups B and
C after the ﬁrst operation. Rats were caged separately and left for a
21-day recovery period. During this period, rats wereweighed daily
and none received estrogen or any other medications.
Second operation
Eight rats died during the recovery period: two from Group A
and three from Groups B and C. Three weeks after the ﬁrst opera-
tion, at a second-look laparotomy, vitality of the endometriotic
implants and the presence of cystic structures were evaluated in
Figure 1. Flowchart of the study indicating operation times and interventions. IV ¼ intravenous.
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Ectopic tissue was identiﬁed and three dimensions of the implant
(length, width, and height) were measured using a digital milli-
metric caliper (Elite 600 digital caliper-70416, Mercier _Inc., Levis,
Canada; Figure 2). The spherical volume of the ectopic uterine tis-
sue was calculated using the ellipsoid formula:
[V (mm3) ¼ 0.52 length (mm)  width (mm)  height (mm)] and
recorded (V1). (1)Figure 2. Measurement of ectopic tissue (length, width, and height) using a digital
millimetric caliper at the second laparotomy.
Figure 3. (A) Histopathological appearance of an implant in Group A (hematoxylineeosi
appearance of an implant in Group B (hematoxylineeosin staining). Epithelial score is 2 (mo
layer). (C) Histopathological appearance of an implant at Group C (control group). (hematoAfter the second operation, 500 mg/kg intravenous vitamin C
(Redoxon ampoule) was given every 2 days to the rats in Group B
(n ¼ 8) until the third operation. Rats in Group C (n ¼ 8) did not
receive vitamin C or any other medications throughout the study.
Third operation
The third laparotomy was carried out 21 days after the second
operation, and the remaining 25 rats were sacriﬁced by ketamine
anesthesia. Implant volumes were measured (V2). Two physicians
blinded to the groups performed all surgeries and measurements.
Endometrial foci were excised and subjected to histopathological
examination after being ﬁxed in a 10% formalin solution.
Histopathological examination
Endometriotic foci with surrounding normal tissue were
extracted for the histopathologic evaluation, samples were
embedded inparafﬁn blocks in the Pathology Laboratory (Pathology
Laboratory of Ankara Education and Research Hospital, Ankara,
Turkey), and 4e6 mm cross-sections were prepared and stained by
hematoxylineeosin (Figures 3Ae3C). Specimens were examined
under a light microscope. Persistence of epithelial cells in endo-
metrial implants was evaluated semiquantitatively as follows:
3 ¼ well-preserved epithelial layer; 2 ¼ moderately preserved
epithelium with leukocyte inﬁltrate; 1 ¼ poorly preserved epithe-
lium (occasional epithelial cells only); and 0 ¼ no epithelium [29].
The stromal elements and ﬁbrosis around the endometric foci were
evaluated by Masson's trichrome staining: Grade 0, no ﬁbrosis;
Grade 1, minimal ﬁbrous tissue growth; Grade 2, irregular ﬁbrousn staining). Epithelial score is 1 (poorly preserved epithelium). (B) Histopathological
derately preserved epitheliumwith leukocyte inﬁltrate and detachments from the basal
xylineeosin staining). Epithelial score is 3 (well preserved epithelium).
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(Figures 4Ae4D) [30,31]. The same pathologist who was blinded to
the study groups examined all tissues.
Statistical analysis
Data are given as median (range) and mean ± standard devia-
tion. Statistical analyses were performed using SPSS version 15.0
(SPSS Inc., Chicago, IL, USA). Non-normally distributed metric var-
iables were analyzed by KruskaleWallis test and ManneWhitney U
test. Implant volumes within the groups were compared statisti-
cally usingWilcoxon signed rank test, while the implant volumes of
the groups and differences between V1 and V2 were compared
using the KruskaleWallis test and ManneWhitney U test, respec-
tively. A p value < 0.05 was considered as statistically signiﬁcant.
Results
Three parameters were evaluated during the study: implant
volumes, weight changes, and histopathological scores.
No statistically signiﬁcant difference between the groups was
determined in terms of weight change (Table 1) and histological
scores (Tables 2 and 3; epithelial cell score and Masson's trichromeFigure 4. (A) Histopathological appearance of an implant in Group A (Masson's trichrome s
ﬁbrosis and collagen formation area (blue areas) in the viewed section. (B) Histopathologica
and trichrome staining score is considered as 3 reﬂecting ﬁbrosis and collagen formation a
(Masson's trichrome staining). Epithelial score is 2 and trichrome staining score is considere
preparations from the same rat of the control group are viewed.
Table 1
Weights of rats in the control and treatment groups and statistical analysis of weight ch
Weight (g) Group A
(n ¼ 9)
Group B
(n ¼ 8)
Group C
(n ¼ 8)
Weight 1 241.11 ± 21.23 235.25 ± 13.63 238.25 ±
Weight 2 238.44 ± 18.50 237.50 ± 13.92 236.25 ±
Data are presented as mean ± standard deviation.score; p > 0.05). Although ectopic endometrial glands and stroma
seemed to be more preserved in specimens from the control group,
there was no statistical signiﬁcance between the histological scores
of the groups.
Signiﬁcant differences were determined in endometriotic
implant volumes. Both Groups A and B were signiﬁcantly different
from the control group when the differences between volumes (V1
e V2) were compared (Table 4).
Group A had the lowest implant volume during the second and
third laparotomies, and the difference between Groups A and B was
statistically signiﬁcant (p ¼ 0.012). A signiﬁcant regression was
detected in Group B (109.93 ± 104.70 mm3 vs. 42.45 ± 60.35 mm3,
p ¼ 0.025) after the treatment with vitamin C, while an increase in
the volume was found in the control group that received no
medication (34.71 ± 2.81 vs. 59.22 ± 3.61; Table 4).
Discussion
Exact pathogenic processes that underlie the development and
provide maintenance of endometriosis are still unclear [1,5]. As
known to date about the pathophysiology of endometriosis, in-
duction and progression of the disease require a proinﬂammatory
environment, increased angiogenesis, resistance to apoptosis,taining). Epithelial score is 1 and trichrome staining score is considered as 2 reﬂecting
l appearance of an implant in Group B (Masson's trichrome staining). Epithelial score 2
rea. (C and D) Histopathological appearance of an implant in Group C (control group)
d as 3 reﬂlecting the common area of ﬁbrosis and collagen formation (blue areas). Two
anges during the experiments.
Inter- & intragroup assessments Statistical analysis
13.99 0.777 p > 0.05
15.62 0.962 p > 0.05
Table 2
Histological cell scores among groups.a
Histological scores Group A Group B Group C
Mean 1.0 1.62 2.0
Median 1.0 1.5 2.0
Minemax 0.0e3.0 0.0e3.0 1.0e3.0
Standard deviation 0.86 1.06 0.92
a KruskaleWallis test and histological scoring showed no statistically signiﬁcant
difference between groups (p ¼ 0.096).
Table 3
Trichrome ﬁbrosis scores between groups.a
Trichrome scores Group A Group B Group C
Mean 2.22 1.62 2.12
Median 2.0 2.0 2.0
Minemax 1.0e3.0 1.0e2.0 1.0e3.0
Standard deviation 0.83 0.51 0.83
a The difference in the KruskaleWallis test trichrome score between groups was
not statistically signiﬁcant (p ¼ 0.234).
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oxidative stress [5,7e9]. A novel medical treatment while having an
impact on many of these steps, but also should not adversely affect
the fecundity and also should have minimal adverse effect proﬁle
that makes the long-term use possible for endometriosis.
Most vitamin C studies in the literature are cancer studies based
on antiangiogenic and -tumoral effects [20,29]. There are also
studies that mention anti-inﬂammatory and -angiogenic effects of
vitamin C. Knowing these features of vitamin C, our study was
designed with the goal of investigating the effect of vitamin C on
endometriotic implants.
The results of the experiments of this study demonstrate that
vitamin C effectively causes a signiﬁcant decrease in the volume of
endometriotic tissue and may support the hypothetical value of
antioxidant therapy in endometriosis. Group A, which received
vitamin C at the induction of endometriosis and continued during
the study, had the lowest implant volumes. This group may be
considered as the “prophylaxis” group. The implant volume
measured during the third laparotomy (42 days after the induction)
decreased signiﬁcantly in Group B between the second and third
operationsdthe group that received vitamin C starting after the
second operation and may be considered as the “treatment” group.
In the control group that had no treatment, implant volumes
continued to increase during the study (42 days). The histopatho-
logical structure of the disease was not found to be any different in
the two treatment groups. This might be related to the short
duration of the treatment.
Santanam et al [14] used a combination of vitamin C and vitamin
E as antioxidants, and found that chronic pain improved signiﬁ-
cantly in the group that received antioxidant supplementation inTable 4
Differences of implant volumes among groups.
Variable Group A
No. of rats 9
Mean volume of the implants at the 2nd laparotomy (mm3) 18.7539 ± 1.230
Mean volume of the implants at the 3rd laparotomy (mm3) 11.4073 ± 8.495
Differences between volumes 7.34 ± 24.29c
pe 0.953
a Comparison of groups done by KruskaleWallis test and ManneWhitney U tests.
b Statistically signiﬁcant difference from Group B (p ¼ 0.012).
c Statistically signiﬁcant difference from Group B (p ¼ 0.043).
d Statistically signiﬁcant difference from the control group (p ¼ 0.09).
e Comparison within a group done by Wilcoxon signed rank test.comparison with the placebo group. Furthermore, there was a
decrease in peritoneal inﬂammatory markers in this group. Other
studies have demonstrated that NFkB inhibitors prevent proin-
ﬂammatory signal transmission in the endometriosis of nude mice
models by suppressing the development of endometriosis [32], and
all medications that are currently used for treatment of endome-
triosis act through suppression of NFkB activation [31]. In endo-
metriotic cells, NFkB appears to be constitutively activated, and
suppression byNFkB inhibitors or proteasome inhibitors suppresses
proliferation in vitro. Furthermore, it has also been shown that
antioxidant intake provides a protective effect fromNFkB activation
and that it treats the symptoms caused by the disease [11,14].
Ascorbic acid with a concentration higher than 199 mg/dL demon-
strates a noncytotoxic anticancer activity by preventing cell migra-
tion and angiogenesis [18]. All these studies imply that vitamin C
may play a protective or therapeutic role in endometriosis.
Studies have shown that the diets of womenwith endometriosis
include less antioxidant, and antioxidant intake is beneﬁcial for
decreasing pelvic pain [14,33]. Hence, the use of vitamin C is
encouraging in terms of its side effects, cost, and ease of access, at
least for symptomatic relief. Durak et al [26] investigated the effect
of different doses of vitamin C supplementation via oral gavage,
beginning the day after implantation, on endometriotic cyst vol-
ume in a rat model. They reported a signiﬁcant dose-related
reduction in the weight and volume of the cysts in the study
group compared with that of the control group. Similar to our
study, they failed to demonstrate a signiﬁcant difference in the
stromal and glandular tissue contents of the groups. It is already
known that due to the strict control of intestinal absorption of
vitamin C, oral intake is not sufﬁcient for reaching therapeutic
plasma levels [15]. Therefore, in the present study, we gave vitamin
C via intravenous administration, and also the timing of the treat-
ment was different as we aimed to investigate both prophylactic
and therapeutic effects of vitamin C on endometriosis.
This is a preliminary study investigating a novel therapeutic
approach that seems to promise a favorable outcome. Several
limitations to this study need to be acknowledged; the ﬁrst limi-
tation, common with all studies on rats, is that rats are different
from women regarding reproductive biology and anatomy, as they
do not menstruate and do not have endometriosis spontaneously
[23]. Vernon and Wilson [25], after performing various in-
terventions in their study in 1985, stated that autotransplantation
of uterine tissues directly to the peritoneal wall was the only
technique that achieved developing endometriotic implants made
up of both glands and endometrial stroma. Endometriosis in our
model was induced according to these ﬁndings.
The second limitation is that the current study does not include
a comparison of the effects of a well-known antioxidant agent or a
Gonadotropin-Releasing Hormone agonist (GnRH agonist), which
are proven therapies used in humans. [34]. As all new therapeutic
agents, further investigations are needed in order to assess theGroup B Control group pa
8 8
13b 109.9367 ± 104.70553 34.7153 ± 2.81311 0.025
56 42.4597 ± 60.35632 59.2247 ± 3.61833 0.672
67.47 ± 91.85d 24.50 ± 48.90 0.022
0.025 0.401
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As we mentioned before, in this preliminary study with small size
of animal samples, according to the ethical limitations of the animal
studies, we speculated the preventive and regressive effects of
“high dose” intravenous vitamin C in an endometriosis model.
Different dose regimens and additional settings including GnRH
agonists will be our future direction for investigating the effects of
vitamin C properly.
In conclusion, wemay speculate that vitamin C has a remarkable
effect on the reduction of endometrial implant induction and
growth, and further research is required to improve targeted in-
terventions aimed at the prophylaxis and treatment of human
endometriosis. The use of systemic high-dose vitamin C as a po-
tential therapeutic agent in the treatment of endometriosis is at an
experimental stage. These ﬁndings can be useful if they are sup-
ported by subsequent research carried out with a greater number of
cases and various different experimental designs.
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